Scientists test new nasal spray to stop whooping cough
NCT ID NCT02453048
Summary
This study tested a new, higher-dose version of a nasal spray vaccine designed to prevent whooping cough. It involved 54 healthy adults to see if the spray was safe and if it triggered a good immune response. Researchers also checked if the vaccine's weakened bacteria could briefly live in the nose, which might help provide better protection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WHOOPING COUGH are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Karolinska University Hospital
Huddinge, Stockholm County, 141 86, Sweden
Conditions
Explore the condition pages connected to this study.